Cargando…
Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis
The induction of an effective immune response is critical for the success of mRNA-based therapeutics. Here, we developed a nanoadjuvant system compromised of Quil-A and DOTAP (dioleoyl 3 trimethylammonium propane), hence named QTAP, for the efficient delivery of mRNA vaccine constructs into cells. E...
Autores principales: | Touray, Bubacarr J.B., Hanafy, Mostafa, Phanse, Yashdeep, Hildebrand, Rachel, Talaat, Adel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286238/ https://www.ncbi.nlm.nih.gov/pubmed/37359562 http://dx.doi.org/10.3389/fimmu.2023.1188754 |
Ejemplares similares
-
Genome analysis of Mycobacterium avium subspecies hominissuis strain 109
por: Matern, William M., et al.
Publicado: (2018) -
Mycobacterium avium subspecies hominissuis in Crohn’s disease: a case report
por: Zhang, Peilin, et al.
Publicado: (2017) -
Systemic infection of Mycobacterium avium subspecies
hominissuis and fungus in a pet dog
por: KIM, Myung-Chul, et al.
Publicado: (2015) -
Establishing Caenorhabditis elegans as a model for Mycobacterium avium subspecies hominissuis infection and intestinal colonization
por: Everman, Jamie L., et al.
Publicado: (2015) -
Clinical findings and treatment of disseminated ‘Mycobacterium
avium subspecies hominissuis’ infection in a domestic
cat
por: KANEGI, Ryoji, et al.
Publicado: (2019)